Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of new orally active prostaglandin D2 receptor antagonists.
Iwahashi M, Naganawa A, Kinoshita A, Shimabukuro A, Nishiyama T, Ogawa S, Matsunaga Y, Tsukamoto K, Okada Y, Matsumoto R, Nambu F, Oumi R, Odagaki Y, Katagi J, Yano K, Tani K, Nakai H, Toda M. Iwahashi M, et al. Among authors: naganawa a. Bioorg Med Chem. 2011 Nov 15;19(22):6935-48. doi: 10.1016/j.bmc.2011.08.065. Epub 2011 Sep 2. Bioorg Med Chem. 2011. PMID: 21982795
A practical synthesis and biological evaluation of 9-halogenated PGF analogues.
Tani K, Naganawa A, Ishida A, Egashira H, Odagaki Y, Miyazaki T, Hasegawa T, Kawanaka Y, Sagawa K, Harada H, Ogawa M, Maruyama T, Nakai H, Ohuchida S, Kondo K, Toda M. Tani K, et al. Among authors: naganawa a. Bioorg Med Chem. 2002 Jun;10(6):1883-94. doi: 10.1016/s0968-0896(02)00008-1. Bioorg Med Chem. 2002. PMID: 11937346
Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A, Saito T, Nagao Y, Egashira H, Iwahashi M, Kambe T, Koketsu M, Yamamoto H, Kobayashi M, Maruyama T, Ohuchida S, Nakai H, Kondo K, Toda M. Naganawa A, et al. Bioorg Med Chem. 2006 Aug 15;14(16):5562-77. doi: 10.1016/j.bmc.2006.04.038. Epub 2006 May 12. Bioorg Med Chem. 2006. PMID: 16697646
Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists.
Naganawa A, Matsui T, Saito T, Ima M, Tatsumi T, Yamamoto S, Murota M, Yamamoto H, Maruyama T, Ohuchida S, Nakai H, Kondo K, Toda M. Naganawa A, et al. Bioorg Med Chem. 2006 Oct 1;14(19):6628-39. doi: 10.1016/j.bmc.2006.05.076. Epub 2006 Jun 19. Bioorg Med Chem. 2006. PMID: 16784865
Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.
Ishida A, Okabe Y, Matsushita T, Sekiguchi T, Nishio T, Komagata T, Iwaki M, Miyata H, Katagi J, Naganawa A, Maruyama T, Imagawa A. Ishida A, et al. Among authors: naganawa a. Bioorg Med Chem. 2021 Nov 1;49:116424. doi: 10.1016/j.bmc.2021.116424. Epub 2021 Sep 25. Bioorg Med Chem. 2021. PMID: 34626901
23 results